Literature DB >> 19471772

[Thiobarbituric acid reactive substances as an index of lipid peroxidation in sevoflurane-treated rats.].

Francisco José Lucena Bezerra1, Adriana Augusto Rezende, Sara Jane Rodrigues, Maria das Graças Almeida.   

Abstract

BACKGROUND AND OBJECTIVES: Sevoflurane is a fluorinated ether with low blood solubility and biotransformed by an oxidative enzymatic liver system involving cytochrome P450 2E1. Lipid peroxidation occurs during ethers biotransformation process under action of cytochrome P450, a possible mechanism for liver and kidney toxicity promoted by such compounds. This study aimed at determining the levels of substances reactive to thiobarbituric acid (TBARS), as an index for lipid peroxidation in sevoflurane-treated rats, previously treated or not with isoniazid, enzymatic inducer of cytochrome P450 2E1.
METHODS: Forty two male Wistar rats were randomly distributed in 4 groups receiving respectively: G1 - 1 L.min-1/60 minutes of 100% oxygen for 5 consecutive days; G2 - 4% sevoflurane in 1 L.min-1/60 minutes of 100% oxygen for 5 consecutive days; G3 - intraperitoneal isoniazid (50 mg.kg-1/day) for 4 consecutive days and then treated as G1; G4 - intraperitoneal isoniazid (50 mg.kg-1/day) for 4 consecutive days and then treated as G2. Animals were sacrificed 12 hours after the last treatment, plasma was collected for TBARS analysis and the liver left lobe and both kidneys were removed for histological evaluation.
RESULTS: Results have shown increased TBARS levels in G3 and G4, with mild increase in G2. Histological evaluation has revealed focal liver necrosis in rats pretreated with isoniazid (G3).
CONCLUSION: Sevoflurane has promoted lipid peroxidation only when associated to isoniazid.

Entities:  

Year:  2004        PMID: 19471772     DOI: 10.1590/s0034-70942004000500004

Source DB:  PubMed          Journal:  Rev Bras Anestesiol        ISSN: 0034-7094            Impact factor:   0.964


  2 in total

1.  In-vitro and in-vivo functional observation studies to establish therapeutic potential of alpha-ketoglutarate against methotrexate induced liver injury.

Authors:  Lalita Mehra; Aditi Bhattacharya; Harish Rawat; Amit Kumar; Abhinav Jaimini; Gaurav Mittal
Journal:  Biomed J       Date:  2020-05-23       Impact factor: 4.910

2.  Fast food diet with CCl4 micro-dose induced hepatic-fibrosis--a novel animal model.

Authors:  Tarak K Chheda; Pratibha Shivakumar; Satish Kumar Sadasivan; Harish Chanderasekharan; Yogananda Moolemath; Anup M Oommen; Jagannath R Madanahalli; Venkataranganna V Marikunte
Journal:  BMC Gastroenterol       Date:  2014-05-10       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.